We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Adoption of EMA Trial Transparency Policy Postponed Until October
Adoption of EMA Trial Transparency Policy Postponed Until October
July 10, 2014
The European Medicines Agency’s management board has delayed formal adoption of a controversial clinical trial transparency policy, pending further clarifications on final wording and practical considerations at its Oct. 2 meeting.